ArticleEuropean heart journal. Case reports2025
Beyond the numbers: the challenge of FFR-guided strategies in multivessel disease undergoing CABG-think differently.
Article in European heart journal. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Fractional flow reserve (FFR) is a cornerstone in guiding percutaneous coronary intervention (PCI) for intermediate coronary lesions, supported by robust evidence and guidelines. Its application in coronary artery bypass grafting (CABG), however, remains uncertain, with no validated thresholds or standardized integration into surgical planning. Case summary: We report the case of a 69-year-old man with three-vessel coronary artery disease who underwent total arterial revascularization using a bilateral internal mammary artery Y-graft. Despite a pre-operative FFR of 0.78 in the left anterior descending artery (LAD), intra-operative transit-time flow measurements revealed severely impaired graft flow, prompting revision of the left internal mammary artery-LAD anastomosis. Post-revision flow remained poor. At 3-month follow-up, angiography confirmed graft failure, yet myocardial perfusion imaging showed no significant ischaemia in the LAD territory. Discussion: This case underscores the limitations of applying FFR as a primary determinant in surgical revascularization. In the absence of validated cut-offs for CABG, reliance on PCI-based thresholds may lead to inappropriate grafting strategies, competitive flow, and early graft failure. Fractional flow reserve should be seen as a physiological adjunct-not a directive-within a broader framework of clinical, anatomical, and intra-operative assessment. Current evidence does not support replacing angiographic judgment with FFR in surgical decision-making. The integration of FFR into CABG planning requires a nuanced, individualized approach, guided by future trials and multidisciplinary expertise. Conclusion: In surgical revascularization, the question is not whether a lesion crosses an FFR threshold, but how to best achieve durable myocardial protection.FFR should guide strategy, not dictate it-think differently.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.